Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1992-12-15
1995-06-20
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31185
Patent
active
054261228
ABSTRACT:
Methods for treatment of humans and other animals with dimercaptosuccinic acid (DMSA). DMSA is administered to reduce levels of silicon in blood and tissue, reduce blood pressure, improve kidney function, prevent or retard the progression of chronic renal failure, treat the accumulation of silicon in advanced kidney disease, decrease accumulation of reactive oxygen metabolites, increase superoxide dismutase activity, and/or prevent the onset or improve the current status of senile dementia or Alzheimer's disease.
REFERENCES:
patent: 4962127 (1990-10-01), Gonick et al.
Aposhian, H. V. "DMSA & DMPS--Water Soluble Antidotes for Heavy Metal Poisoning," Ann. Rev. Pharmacol. Toxicol., 23:193-215 (1983).
Cantilena, L. R. et al., "The Effect of Repeated Administration of Several Chelators on the Distribution and Excretion of Cadmium", Tox. Appl. Pharm., 66:361-67 (1982).
Cloix, J. F. et al., "Plasma Protein Changes in Primary Hypertension in Humans and Rats", Hypertension, 5:128-34 (1983).
Domingo, J. L. et al., "Acute Aluminum Intoxication: A Study of the Efficacy of Several Antidotal Treatments in Mice", Res. Com. Chem. Pathol. Pharm., 53:93-104 (1986).
Domingo, J. L. et al., "Developmental Toxicity of Subcutaneously Administered meso-2,3 Dimercaptosuccinic Acid in Mice", Fund. Appl. Tox., 11:715-22 (1988).
Gonick, H. C. et al., "Comparison of Low Molecular Weight Plasma and Urine Na-K-ATPase Inhibitors/Hypertensive Factors " (1973).
Handmaker, H. et al., "Clinical Experience with .sup.99m Tc-DMSA (Dimercaptosuccinic Acid), A New Renal-Imaging Agent", J. Nucl. Med., 16:28-32 (1973).
Hoefnagel, C. A. et al., "New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid Carcinoma", Clin. Nucl. Med., 13:159-65 (1988).
Ignarro, L. J., "Biosynthesis and Metabolism of Endothelium-Derived Nitric Oxide", Ann. Rev. Pharmacol. Toxicol., 30:535-60 (1990).
John, A. et al., "Identification of a So-far Not Characterized Human Serum Protein Associated With Essential Hypertension", Electrophoresis, 6:292-95 (1985).
Kondo, K. et al., "Simultaneous Measurement of Endothelium-Derived Relaxing Factor By Bioassay and Guanylate Cyclase Stimulation", Br. J. Pharmacol., 98:630-36 (1989).
Liang Yu-i et al., "The Antidotal Effects of Sodium Dimercaptosuccinate and Bal-Glucoside Against Tartar Emetic", Acta Physiol. Sin., 21:24-32 (1957).
Llobet, J. M. et al., "Comparison of the Effectiveness of Several Chelators After Single Administration on the Toxicity, Excretion and Distribution of Cobalt", Arch. Toxicol., 58:278-81 (1986).
Llobet, J. M. et al., "Antidotes for Zinc Intoxication in Mice", Arch Toxicol., 61:321-23 (1988).
Luscher, T. F., "Imbalance of Endothelium-derived Relaxing and Contracting Factors", Am. J. Hypertension, 3:317-30 (1990).
Luscher, T. F. et al., "Endothelium-derived Relaxing and Contracting Factors: Perspectives in Nephrology", Kidney Int'l., 39:575-90 (1991).
Lyons, K. P. et al., "Mycardial Infarct Imaging in Patients with Technetium-99m 2,3-Dimercaptosuccinic Acid--Superiority of Technetium-99m Pyrophospahte", Clin. Nucl. Med., 12:514-18 (1987).
Maiorino, R. M. et al., "Determination and Metabolism of Dithiol-Chelating Agents: Electrolytic and Chemical Reduction of Oxidized Dithiols in Urine", Anal. Biochem., 160:217-26 (1987).
Morich, F. J. et al., "Characteristic Changes of Plasma Proteins in the Dahl Hypertensive Rat Strain (DS) During the Development of Hypertension", J. Hypertension, 3:249-53 (1985).
Nardi, R. et al., "Characteristic Variation in the Plasma Proteins in Essential Hypertension", Clinical & Experimental Hypertension, 3:775-81 (1981).
Shainkin-Kestenbaum, R. et al., "Inhibition of Superoxide Dismutase Activity by Silicon", J. Trace Elem. Electrolytes Health Dis., 4:97-99 (1990).
Van de Voorde, A. et al., "Isolation of a Plasma Protein Observed in Patients with Essential Hypertension", Biochem. Biophys. Res. Com., 111:1015-21 (1983).
Watkinson, J. C. et al., "An Evaluation of the Uptake of Technetium-99m(v) Dimercaptosuccinic Acid in Patients with Squamous Carcinoma of the Head and Neck", Clin. Otolaryngol., 12:405-11 (1987).
Webb, R. C. et al., "In Vivo and In Vitro Effects of Lead on Vascular Reactivity in Rats", Am. Physiol. Soc., H211-H216 (1981).
Weber, M. A. et al., "Effects of a Human-Derived Sodium Transport Inhibitor on In Vitro Vascular Reactivity", Am. J. Hypertension, 2:754-61 (1989).
Gonick Harvey C.
Khalil-Manesh Farhad
Weiler Elmar W. J.
Cedars-Sinai Medical Center
Criares T. J.
Henley III Raymond
LandOfFree
Methods for reducing blood pressure with dimercaptosuccinic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for reducing blood pressure with dimercaptosuccinic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing blood pressure with dimercaptosuccinic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1844351